Chugai Pharmaceutical Co (TSE:4519) YoY EPS Growth : 34.43% (As of Jun. 2024)

View and export this data going back to 1956. Start your Free Trial

What is Chugai Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Chugai Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Jun. 2024 was 34.43%.

Chugai Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was 円67.97.

Chugai Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for Chugai Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co YoY EPS Growth Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

70.28

36.24

41.09

23.57

-13.08

Chugai Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															14.42	-11.00	1.21	34.43	41.13

Chugai Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Chugai Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(197.8	-	227.57)	/	\| 227.57 \|
=	-13.08 %

Chugai Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (Q: Jun. 2024 )
=	(Earnings per Share (Diluted) (Q: Jun. 2024 )	-	Earnings per Share (Diluted) (Q: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2023 )) \|
=	(67.97	-	50.56)	/	\| 50.56 \|
=	34.43 %

Chugai Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (TSE:4519) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA CUP:Germany

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and covid-19 patients.

Chugai Pharmaceutical Co Headlines

No Headlines